PT - JOURNAL ARTICLE AU - Xiaofei Sun AU - Tianjia Guan AU - Tao Xue AU - Chun Fan AU - Meng Yang AU - Yuxian Meng AU - Tianwei Zhang AU - Bahabaike Jiangtulu AU - Fei Wu AU - Jiwei Li TI - Analysis on Action Tracking Reports of COVID-19 Informs Control Strategies and Vaccine Delivery in Post-Pandemic Era AID - 10.1101/2021.04.08.21254953 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.08.21254953 4099 - http://medrxiv.org/content/early/2021/04/25/2021.04.08.21254953.short 4100 - http://medrxiv.org/content/early/2021/04/25/2021.04.08.21254953.full AB - Understanding the spread of SARS-CoV-2 provides important insights for control policies such as social-distancing interventions and vaccine delivery in the post-pandemic era. In this work, we take the advantage of action tracking reports of confirmed COVID-19 patients, which contain the mobility trajectory of patients. We analyzed reports of patients from April 2020 to January 2021 in China, a country where the residents are well-prepared for the “new normal” world following COVID-19 spread. We developed natural language processing (NLP) tools to transform the unstructured text of action-tracking reports to a structured network of social contacts. An epidemiology model was built on top of the network. Our analysis provides important insights for the development of control policies. Under the “new normal” conditions, we find that restaurants, locations less protected by mask-wearing, have a greater risk than any other location categories, including locations where people are present at higher densities (e.g., flight). We find that discouraging railway transports is crucial to avoid another wave of breakout during the Chunyun season (a period of travel in China with extremely high traffic load around the Chinese New Year). By formalizing the challenge of finding the optimal vaccine delivery among various different population groups as an optimization problem, our analysis helps to maximize the efficiency of vaccine delivery under the general situation of vaccine supply shortage. We are able to reduce the numbers of infections and deaths by 7.4% and 10.5% respectively with vaccine supply for only 1% of the population. Furthermore, with 10% vaccination rate, the numbers of infections and deaths further decrease by 52.6% and 78.1% respectively. Our work will be helpful in the design of effective policies regarding interventions, reopening, contact tracing and vaccine delivery in the “new normal” world following COVID-19 spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the action reports used in this work are publicly available on the websites of provincial centers for Disease Control and Prevention (e.g., http://wsjkw.hlj.gov.cn/ and http://wsjkw.hebei.gov.cn/). Reports are also reproduced online by news websites and can be found on social media websites such as Weibo. There are no restrictions to date on the use of the data for research purposes. The SmartStep data are from a commercial product, owned by the third party, and will be available from the corresponding author upon reasonable request. http://wsjkw.hlj.gov.cn http://wsjkw.hebei.gov.cn